A Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Pancreatic Cancer Patients Receiving at Least 2 Prior Therapies

Sponsors and collaborators

Immunomedics, Inc.


Continue Reading

Contact

Michael Sosnowski  973-605-8200 ext 144   [email protected]

Investigator

William A Wegener, MD, PhD  Immunomedics, Inc.

ClinicalTrials.gov Identifier

NCT01510561